Drug intelligence / Profile preview

Dermalex Eczema

Development stage
Unknown
Lead developer
Perrigo
Modality
Device-based Delivery → Drug Delivery Systems
Administration
Topical
01

Overview

Dermalex Eczema is a non-steroidal topical cream developed for the treatment of mild to moderate atopic dermatitis (eczema). Classified as a medical device or cosmetic-type formulation rather than a traditional pharmaceutical drug, it is designed to restore and fortify the skin barrier. Its primary active components include a skin-identical ceramide complex and a proprietary MagnoLite complex (modified alumino-silicates and alkaline earth minerals). These ingredients work synergistically to replenish missing natural ceramides and activate the skin's own repair mechanisms, creating a protective layer that prevents moisture loss and blocks environmental triggers. The product is free from corticosteroids, calcineurin inhibitors, artificial colorings, and parabens, making it suitable for long-term use in both adults and children aged 6 years and over. It was studied in randomized trials in collaboration with the Amsterdam Medical Center (AMC) and is marketed as a standalone or adjunct therapy.

Brand names
Dermalex EczemaDermalex Eczema Treatment
Other names
Dermalex Eczema cream

Beyond the preview

Go deeper on Dermalex Eczema.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dermalex Eczema.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call